New bipartisan bill aims to speed up clinical trials for rare disease treatments
A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients.
According to CNBC, a new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients.
This health story centres on the United States.
Why it matters
Health developments can affect patients, healthcare providers and public-health planning.
Key details
- Location
- United States · Americas
- Reported by
- CNBC
- First reported
- Section
- Health
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at CNBCSpotted an error? Request a correction · How this summary was produced
Related Stories
What you might not know about Patriots running back Rhamondre Stevenson
Stevenson does all the little things for the Patriots, and he's on the cusp of 100 carries for the sixth straight season.
Wysh List: Why NHL fighting is up -- and getting noticed
Through 120 games, there were 34 games with one or more fights, up over the last two seasons (25 and 26).
Six players whose improved play should continue
Six fantasy football players whose production is surging and why you can expect it to continue.
2027 World Cup teams ranked: All 49 countries that can win next summer
There are 49 national teams that could win the FIFA Women's World Cup next summer.
Why getting dressed can cause daily meltdowns for some people
Naomi Potter set up her own clothes company after feeling overwhelmed by the feeling of some clothes.
Experts alarmed by ‘less transparent’ CDC as US measles deaths rise
Agency declines to reveal in which state latest measles death occurred as it delays reporting other measles deaths The US Centers for Disease…
MI5 spied on Nye Bevan for more than 20 years, newly released files show
He came to its attention in the 1930s when he was considered a left-wing firebrand.
High health costs squeeze workers, even if you have good insurance through a job
About 157 million Americans get their health insurance through work.